Insider Trading History of Warnecke Steve B

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Warnecke Steve B since 2007. This trader's CIK number is 1225408. At the time of last reporting, Warnecke Steve B was the Chairman, CEO of Evolutionary Genomics, Inc.. (stock ticker symbol FNAM). Also see all insider trading activities at Evolutionary Genomics, Inc..

Note that in the past WARNECKE STEVE B also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Evolutionary Genomics, Inc. (FNAM) by Warnecke Steve B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 FNAM 0 $0 0 $0 66,667 $36,666

Yearly summary of insider trading at Evolving Systems Inc (EVOL) by Warnecke Steve B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 EVOL 48,500 $38,485 0 $0 0 $0
2007 EVOL 56,911 $105,285 0 $0 0 $0


Insider trading activities at 2 companies by Warnecke Steve B:

1. Evolutionary Genomics, Inc. (FNAM)

2. Evolving Systems Inc (EVOL)

Table 1. Insider trading of Evolutionary Genomics, Inc. (FNAM) by Warnecke Steve B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-05-23 FNAM Option Ex 66,667 .55 36,666

Table 2. Insider trading of Evolving Systems Inc (EVOL) by Warnecke Steve B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-12-10 EVOL Buy 18,500 .80 14,800
2008-12-10 EVOL Buy 9,000 .80 7,200
2008-12-09 EVOL Buy 21,000 .79 16,485
2007-12-04 EVOL Buy 56,911 1.85 105,285

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Warnecke Steve B (Chairman, CEO of Evolutionary Genomics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.